Fennec Pharmaceuticals Inc Share Price Other OTC
Equities
CA31447P1009
Biotechnology & Medical Research
Sales 2024 * | 50M 4.17B | Sales 2025 * | 71.15M 5.93B | Capitalization | 250M 20.81B |
---|---|---|---|---|---|
Net income 2024 * | 5M 417M | Net income 2025 * | 26M 2.17B | EV / Sales 2024 * | 4.99 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.51 x |
P/E ratio 2024 * |
44.2
x | P/E ratio 2025 * |
9.89
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.71% |
Latest transcript on Fennec Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07/09/07 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/09/07 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 25/11/25 |
Khalid Islam
CHM | Chairman | 67 | 25/14/25 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/09/07 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |